• xbxc1

2018 China New Design Tilmicosin Oral Solution 10% - Tilmicosin Oral Solution 10% – Lihua

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We have advanced equipment. Our products are exported to the USA, the UK and so on, enjoying a good reputation among customers for Tiamulin Injection 10%, Ciprofloxacin Hydrochloride Soluble Powder, Ceftiofur Injection 5%, Welcome any of your inquiries and concerns for our products, we look forward to establishing a long-term business relationship with you in the near future. contact us today.
2018 China New Design Tilmicosin Oral Solution 10% - Tilmicosin Oral Solution 10% – Lihua Detail:

Tilmicosin is a broad-spectrum semi-synthetic bactericidal macrolide antibiotic synthesized from tylosin. It has an antibacterial spectrum that is predominantly effective against Mycoplasma, Pasteurella and Haemophilus spp. and various Gram-positive organisms such as Corynebacterium spp. It is believed to affect bacterial protein synthesis through binding to 50S ribosomal subunits. Cross-resistance between tilmicosin and other macrolide antibiotics has been observed. Following oral administration, tilmicosin is excreted mainly via the bile into the faeces, with a small proportion being excreted via the urine.

Indications

Macrotyl-250 Oral is indicated for the control and treatment of respiratory infections associated with tilmicosin-susceptible micro-organisms such as Mycoplasma spp. Pasteurella multocida, Actinobacillus pleuropneumoniae, Actinomyces pyogenes and Mannheimia haemolytica in calves, chickens, turkeys and swine.

Contra-Indications

Hypersensitivity or resistance to tilmicosin.

Concurrent administration of other macrolides or lincosamides.

Administration to animals with an active microbial digestion or to equine or caprine species.

Parenteral administration, especially in porcine species.

Administration to poultry producing eggs for human consumption or to animals intended for breeding purposes.

During pregnancy and lactation, use only after a risk/benefit assessment by a veterinarian.

Side Effects

Occasionally, a transient reduction in water or (artificial) milk intake has been observed upon treatment with tilmicosin.

Administration and Dosage

For oral administration.

Calves : Twice daily, 1 ml per 20 kg body weight via (artificial) milk for 3 – 5 days.

Poultry : 300 ml per 1000 litre drinking water (75 ppm) for 3 days.

Swine : 800 ml per 1000 litre drinking water (200 ppm) for 5 days.

Note: Medicated drinking water or (artificial) milk should be prepared fresh every 24 h. To ensure a correct dosage, the concentration of the product should be adjusted to the actual fluid intake.

Withdrawal Time

- For meat:

Calves : 42 days.

Broilers : 12 days.

Turkeys : 19 days.

Swine : 14 days.

For Veterinary UseOnly , Keep out of reach of children


Product detail pictures:


Related Product Guide:

We've been proud with the significant shopper fulfillment and wide acceptance due to our persistent pursuit of top of the range both of those on solution and repair for 2018 China New Design Tilmicosin Oral Solution 10% - Tilmicosin Oral Solution 10% – Lihua , The product will supply to all over the world, such as: London, Southampton, Boston, Our products have won an excellent reputation at each of the related nations. Because the establishment of our firm. we have insisted on our production procedure innovation together with the most recent modern day managing method, attracting a sizable quantity of talents within this industry. We regard the solution good quality as our most vital essence character.
  • Previous
  • Next:

  • This company can be well to meet our needs on product quantity and delivery time, so we always choose them when we have procurement requirements.
    5 Stars By Jacqueline from Suriname - 2018.09.23 17:37
    Wide range, good quality, reasonable prices and good service, advanced equipment, excellent talents and continuously strengthened technology forces,a nice business partner.
    5 Stars By Albert from Rio de Janeiro - 2017.03.28 12:22